[1]Liu L, Xia H, Wahlberg N, Belak S, Baule C. Phylogeny, classification and evolutionary insights into pestiviruses. Virology, 2009, 385(2):351-357.
[2]Beer M, Reimann I, Hoffmann B, Depner K. Novel marker vaccines against classical swine fever. Vaccine, 2007, 25(30):5665-5670.
[3]王琴. 猪瘟研究进展,中国兽药杂志, 2012, 47(9): 58-61.
Wang Q. Research of the classical swine fever. Chinese Journal of Veterinary Drug, 2012, 47(9): 58-61. (in Chinese)
[4]王琴. 猪瘟流行现状及中国猪瘟净化策略. 中国猪业, 2012(10): 45-47.
Wang Q. Classical swine fever current situation and control strategies on resent China. China Swine Industry, 2012(10): 45-47. (in Chinese)
[5]Tu C, Lu Z, Li H, Yu X, Liu X, Li Y, Zhang H, Yin. Z. Phylogenetic comparison of classical swine fever virus in China. Virus Research, 2001, 81(1-2): 29-37.
[6]Luo T, Liao S, Wu X, Feng L, Yuan Z, Li H, Liang J, Meng X, Zhang H. Phylogenetic analysis of the E2 gene of classical swine fever virus from the Guangxi Province of southern China. Virus Genes, 2011, 42(3): 347-354.
[7]Chen N, Hu H, Zhang Z, Shuai J, Jiang L, Fang W. Genetic diversity of the envelope glycoprotein E2 of classical swine fever virus: recent isolates branched away from historical and vaccine strains. Veterinary Microbiology, 2008. 127(3/4): 286-299.
[8]Reimann I, Depner K, Trapp S, Beer M. An avirulent chimeric pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus. Virology, 2004, 322(1): 143-157.
[9]van Gennip H G, van Rijn P A, Widjojoatmodjo M N, de Smit A J, Moormann R J. Chimeric classical swine fever viruses containing envelope protein E(RNS) or E2 of bovine viral diarrhoea virus protect pigs against challenge with CSFV and induce a distinguishable antibody response. Vaccine, 2000, 19(4/5): 447-459.
[10]Kortekaas J, Vloet RP, Weerdmeester K, Ketelaar J, van Eijk M, Loeffen W L. Rational design of a classical swine fever C-strain vaccine virus that enables the differentiation between infected and vaccinated animals. Journal of Virological Methods, 2010, 163(2): 175-185.
[11]Kortekaas J, Ketelaar J, Vloet R P, Loeffen W L. Protective efficacy of a Classical swine fever virus C-strain deletion mutant and ability to differentiate infected from vaccinated animals. Veterinary Microbiology, 2011, 147(1-2):11-18.
[12]Reimann I, Depner K, Utke K, Leifer I, Lange E, Beer M. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope. Veterinary Microbiology, 2010, 142(1-2):45-50.
[13]Sun Y, Li H Y, Tian D Y, Han Q Y, Zhang X, Li N, Qiu H J. A novel alphavirus replicon-vectored vaccine delivered by adenovirus induces sterile immunity against classical swine fever. Vaccine, 2011, 29(46): 8364-8372.
[14]Sun Y, Li N, Li H Y, Li M, Qiu H J. Enhanced immunity against classical swine fever in pigs induced by prime-boost immunization using an alphavirus replicon-vectored DNA vaccine and a recombinant adenovirus. Veterinary Immunology and Immunopathology, 2010, 137(1-2):20-27.
[15]Chen N, Tong C, Li D, Wan J, Yuan X, Li X, Peng J R, Fang W H. Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China. Journal of Virology, 2010, 7(1): 378.
[16]Chen N, Li D, Yuan X, Li X, Hu H, Zhu B, Wan X Y, Fang W H. Genetic characterization of E2 gene of classical swine fever virus by restriction fragment length polymorphism and phylogenetic analysis. Virus Genes, 2010, 40(3): 389-396.
[17]袁雪梅, 陈宁, 陈宇, 王萍, 童超, 李得江, 万婧, 李肖梁, 方维焕. 两种荧光定量PCR方法检测猪瘟病毒的比较及应用. 中国动物传染病学报, 2010, 18(3): 66-72.
Yuan X M, Chen N, Chen Y, Wang P, Tong C, Li D J, Wan J, Li X L, Fang W H. Comparison and application of Sybr green and Taqman based real time PCR assays for detection of classical swine fever virus. Chinese Journal of Animal Infectious Diseases, 2010, 18(3): 66-72. (in Chinese)
[18]Becher P. Avalos Ramirez R, Orlich M, Cedillo Rosales S, König M, Schweizer M, Stalder H, Schirrmeier H, Thiel H J. Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology, 2003, 311(1): 96-104.
[19]Bouma A, de Smit A J, de Kluijver E P, Terpstra C, Moormann R J. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus. Veterinary Microbiology, 1999, 66(2):101-114.
[20]van Rijn P A, van Gennip H G, Moormann R J. An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine, 1999, 17(5): 433-440.
[21]van Rijn P A, Bossers A, Wensvoort G, Moormann R J. Classical swine fever virus (CSFV) envelope glycoprotein E2 containing one structural antigenic unit protects pigs from lethal CSFV challenge. Journal of General Virology, 1996, 77 (11): 2737-2745.
[22]Risatti G R, Borca M V, Kutish G F, Lu Z, Holinka L G, French R A. The E2 glycoprotein of classical swine fever virus is a virulence determinant in swine. Journal of Virology, 2005, 79(6): 3787-3796.
[23]Risatti G R, Holinka L G, Fernandez Sainz I, Carrillo C, Kutish G F, Lu Z. Mutations in the carboxyl terminal region of E2 glycoprotein of classical swine fever virus are responsible for viral attenuation in swine. Virology, 2007, 364(2): 371-382. |